title: Plague vaccines: current developments and future perspectives.
abstract: Despite many decades of intensive studies of Yersinia pestis, the causative agent of plague, there is no safe and efficient vaccine against this devastating disease. A recently developed F1/V subunit vaccine candidate, which relies mainly on humoral immunity, showed promising results in animal studies; however, its efficacy in humans still has to be carefully evaluated. In addition, those developing next-generation plague vaccines need to pay particular attention to the importance of eliciting cell-mediated immunity. In this review, we analyzed the current progress in developing subunit, DNA and live carrier platforms of delivery by bacterial and viral vectors, as well as approaches for controlled attenuation of virulent strains of Y. pestis.
authors.affiliation: Saratov Scientific and Research Veterinary Institute of the Russian Academy for Agricultural Sciences, , Saratov 410028, Russian Federation.
authors.forename: Valentina A
authors.initials: VA
authors.lastname: Feodorova
authors.affiliation: University of Texas Medical Branch , Galveston, Texas 77555, USA.
authors.forename: Vladimir L
authors.initials: VL
authors.lastname: Motin
keywords: Plague; Yersinia pestis; protective antigens; vaccine